Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.
2.

Divergent effects of infliximab and anakinra therapies on macrophage phenotype from patients with refractory rheumatoid arthritis.

Pham TN, Rahman P, Richardson VJ.

Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):491-501.

PMID:
20646344
3.

A novel series of potent cytotoxic agents targeting G2/M phase of the cell cycle and demonstrating cell killing by apoptosis in human breast cancer cells.

Mandal S, Bérubé G, Asselin E, Mohammad I, Richardson VJ, Gupta A, Pramanik SK, Williams AL, Mandal SK.

Bioorg Med Chem Lett. 2007 Sep 1;17(17):4955-60. Epub 2007 Jun 12.

PMID:
17596942
4.

A new platinum complex of triazine demonstrates G1 arrest with novel biological profile in human breast cancer cell line, MDA-MB-468.

Mandal S, Bérubé G, Asselin E, Richardson VJ, Church JG, Bridson J, Pham TN, Pramanik SK, Mandal SK.

Bioorg Med Chem Lett. 2007 Apr 15;17(8):2139-45. Epub 2007 Feb 8.

PMID:
17321743
5.

Progressive and concordant expression of PKC-eta and iNOS phenotypes in monocytes from patients with rheumatoid arthritis: association with disease severity.

Heale CE, Fåhraeus-Van Ree GE, Rahman P, Richardson VJ.

J Histochem Cytochem. 2007 May;55(5):495-503. Epub 2007 Jan 22.

PMID:
17242466
6.
7.
8.
10.

Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation.

Meyers BF, Yusen RD, Lefrak SS, Patterson GA, Pohl MS, Richardson VJ, Cooper JD.

Ann Thorac Surg. 1998 Aug;66(2):331-6.

PMID:
9725365
11.

Humoral response to HSV-1 subunit vaccines--a statistical analysis.

Simms JR, Heath AW, Richardson VJ, Jennings R.

Dev Biol Stand. 1998;92:335-40.

PMID:
9554289
12.

Large scale comparison of adjuvant effects on immunogenicity and protection in a herpes simplex virus type 1 vaccination model.

Simms JR, Heath AW, Richardson VJ, Jennings R.

Biochem Soc Trans. 1997 May;25(2):272S. No abstract available.

PMID:
9191316
13.

Atypical receptor-mediated signal transduction events in the EGF-dependent growth-inhibited cell line, MDA-468.

Church JG, Richardson VJ, Lockwood AG.

J Cell Physiol. 1992 Nov;153(2):373-80.

PMID:
1331123
14.

Toxicity of 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin and doxorubicin in nude mice bearing human tumour xenografts.

Ford CH, Richardson VJ, Pushpanathan C, Ali SK.

Anticancer Res. 1991 Sep-Oct;11(5):1855-62.

PMID:
1768056
15.

Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Ford CH, Richardson VJ, Reddy VS.

Indian J Pediatr. 1990 Jan-Feb;57(1):29-46. Review.

PMID:
2193879
16.

Doxorubicin-anti-carcinoembryonic antigen immunoconjugate activity in vitro.

Richardson VJ, Ford CH, Tsaltas G, Gallant ME.

Eur J Cancer Clin Oncol. 1989 Apr;25(4):633-40.

PMID:
2714340
17.

Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.

Ford CH, Richardson VJ, Tsaltas G.

Cancer Chemother Pharmacol. 1989;24(5):295-301.

PMID:
2788039
18.
19.

Liposomes in antimicrobial chemotherapy.

Richardson VJ.

J Antimicrob Chemother. 1983 Dec;12(6):532-4. No abstract available.

PMID:
6662833
20.

The preoperative detection of axillary lymph node metastases in breast cancer by isotope imaging.

Osborne MP, Payne JH, Richardson VJ, McCready VR, Ryman BE.

Br J Surg. 1983 Mar;70(3):141-4. No abstract available.

PMID:
6831154
21.

Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.

Richardson VJ, Curt GA, Ryman BE.

Br J Cancer. 1982 Apr;45(4):559-64.

22.
23.

Potential applications of radionuclide-labelled liposomes in the detection of the lymphatic spread of cancer.

Osborne MP, Richardson VJ, Jeyasingh K, Ryman BE.

Int J Nucl Med Biol. 1982;9(1):47-51. No abstract available.

PMID:
7085189
24.

Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients.

Richardson VJ, Ryman BE, Jewkes RF, Jeyasingh K, Tattersall MN, Newlands ES, Kaye SB.

Br J Cancer. 1979 Jul;40(1):35-43.

25.

Potential of liposomes as drug-carriers in cancer chemotherapy: a review.

Kaye SB, Richardson VJ.

Cancer Chemother Pharmacol. 1979;3(2):81-5. Review.

PMID:
389479
26.

Radionuclide-labelled liposomes--a new lymph node imaging agent.

Osborne MP, Richardson VJ, Jeyasingh K, Ryman BE.

Int J Nucl Med Biol. 1979;6(2):75-83. No abstract available.

PMID:
113357
27.

Possible tumor localization of Tc-99m-labeled liposomes: effects of lipid composition, charge, and liposome size.

Richardson VJ, Jeyasingh K, Jewkes RF, Ryman BE, Tattersall MH.

J Nucl Med. 1978 Sep;19(9):1049-54.

28.

Potential applications of liposomes to therapy.

Ryman BE, Jewkes RF, Jeyasingh K, Osborne MP, Patel HM, Richardson VJ, Tattersall MH, Tyrrell DA.

Ann N Y Acad Sci. 1978;308:281-307. No abstract available.

PMID:
358897
29.

99mTc-labelled liposomes preparation of radiopharmaceutical and its distribution in a hepatoma patient.

Richardson VJ, Ryman BE, Jewkes RF, Tattersall MH, Newlands ES.

Int J Nucl Med Biol. 1978;5(2-3):118, 121-2, 123. No abstract available.

PMID:
222703
30.

The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver.

Tyrrell DA, Richardson VJ, Ryman BE.

Biochim Biophys Acta. 1977 Apr 27;497(2):469-80.

PMID:
857912
31.

Liposome toxicity in the mouse central nervous system.

Adams DH, Joyce G, Richardson VJ, Ryman BE, Wiśniewski HM.

J Neurol Sci. 1977 Mar;31(2):173-9.

PMID:
839231
32.

Properties of [99mTc] technetium-labelled liposomes in normal and tumour-bearing rats.

Richardson VJ, Jeyasingh K, Jewkes RF, Ryman BE, Tattersall MH.

Biochem Soc Trans. 1977;5(1):290-1. No abstract available.

PMID:
892186
33.

Effect of ethidium bromide on transplanted virus-induced tumor cells.

Richardson VJ, Vodinelich L, Wilson A, Potter CW.

J Natl Cancer Inst. 1976 Oct;57(4):815-9.

PMID:
63562

Supplemental Content

Loading ...
Support Center